Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Some users describe reduced joint pain, faster recovery from injury, and improved tissue healing
In our analysis, the median age of the fluoroquinolone cohort was 5152 years, whereas the median age of the cohort of older adults was 73 years
These range from protein fragments to tiny secreted peptides that alter sperm membrane function
Clinical Indications and Who May Benefit Based on the preclinical literature and emerging clinical use patterns, BPC-157 is most commonly applied in the following areas: Tendon, ligament, and muscle injuries (sprains, partial tears, chronic tendinopathy) Post-surgical tissue healing and recovery acceleration Inflammatory bowel conditions (Crohns, ulcerative colitis, leaky gut syndromes) NSAID-induced gastric damage notably, BPC-157 counteracts aspirin- and ibuprofen-driven mucosal injury Neuropathy and nerve regeneration protocols Systemic inflammation and autoimmune flares Recovery from alcohol-related liver and gut damage It is also increasingly used as a component in broader peptide therapy protocols alongside BPC-157s companion compounds
83730-53-4 Appearance Solid Molecular Weight 222.31 Formula C 8 H 18 N 2 O 3 S Color White to off-white SMILES N[C@H](C(O)=O)CCS(CCCC)(=O)=N Synonyms L-Buthionine sulfoximine
Celecoxibinduced Gastrointestinal, Liver and Brain Lesions in Rats, Counteraction by BPC 157 or L-Arginine, Aggravation by L-NAME
US$ 27.72
US$ 25.46
US$ 28.35
US$ 20.49
US$ 29.28
